Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Tiribelli

Showing results (51-60 of 292) with videos related to

Pageof 30
Sort By:
BMC Biochemistry|June 25, 2002
Low solubility of unconjugated bilirubin in dimethylsulfoxide--water systems: implications for pKa determinationsPasupati Mukerjee, J Donald Ostrow, Claudio Tiribelli
Pediatric Research|March 21, 2003
Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitroJ Donald Ostrow, Lorella Pascolo, Claudio Tiribelli
Hepatology (Baltimore, Md.)|May 1, 2002
Mechanisms of bilirubin neurotoxicityJ Donald Ostrow, Lorella Pascolo, Claudio Tiribelli
International Journal of Molecular Sciences|November 26, 2022
Bilirubin Prevents the TH<sup>+</sup> Dopaminergic Neuron Loss in a Parkinson's Disease Model by Acting on TNF-αSri Jayanti, Rita Moretti, Claudio Tiribelli, et al.
Hepatology International|July 24, 2015
Recent insights into hepatic cancer stem cellsBeatrice Anfuso, Claudio Tiribelli, Caecilia H C Sukowati
Revista Medica De Chile|August 27, 2002
Alcohol-induced liver disease: from molecular damage to treatmentJosé C Fernández Checa, Stefano Bellentani, Claudio Tiribelli
Annals of Hepatology|July 16, 2008
Clinical update on non-alcoholic fatty liver disease and steatohepatitisElisabetta Bugianesi, Stefano Bellentani, Giorgio Bedogni, et al.
BMC Gastroenterology|March 3, 2012
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver diseaseNorberto C Chavez-Tapia, Natalia Rosso, Claudio Tiribelli
International Journal of Molecular Sciences|July 2, 2021
Bilirubin: A Promising Therapy for Parkinson's DiseaseSri Jayanti, Rita Moretti, Claudio Tiribelli, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 20, 2026
Bilirubin as a Modulator of WNK1 Protein Signaling: Implications for Neuroinflammatory DiseasesSri Jayanti, Libor Vítek, Silvia Gazzin, et al.
Pageof 30

Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
BMC Biochemistry|June 25, 2002
Low solubility of unconjugated bilirubin in dimethylsulfoxide--water systems: implications for pKa determinationsPasupati Mukerjee, J Donald Ostrow, Claudio Tiribelli
Pediatric Research|March 21, 2003
Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitroJ Donald Ostrow, Lorella Pascolo, Claudio Tiribelli
Hepatology (Baltimore, Md.)|May 1, 2002
Mechanisms of bilirubin neurotoxicityJ Donald Ostrow, Lorella Pascolo, Claudio Tiribelli
International Journal of Molecular Sciences|November 26, 2022
Bilirubin Prevents the TH<sup>+</sup> Dopaminergic Neuron Loss in a Parkinson's Disease Model by Acting on TNF-αSri Jayanti, Rita Moretti, Claudio Tiribelli, et al.
Hepatology International|July 24, 2015
Recent insights into hepatic cancer stem cellsBeatrice Anfuso, Claudio Tiribelli, Caecilia H C Sukowati
Revista Medica De Chile|August 27, 2002
Alcohol-induced liver disease: from molecular damage to treatmentJosé C Fernández Checa, Stefano Bellentani, Claudio Tiribelli
Annals of Hepatology|July 16, 2008
Clinical update on non-alcoholic fatty liver disease and steatohepatitisElisabetta Bugianesi, Stefano Bellentani, Giorgio Bedogni, et al.
BMC Gastroenterology|March 3, 2012
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver diseaseNorberto C Chavez-Tapia, Natalia Rosso, Claudio Tiribelli
International Journal of Molecular Sciences|July 2, 2021
Bilirubin: A Promising Therapy for Parkinson's DiseaseSri Jayanti, Rita Moretti, Claudio Tiribelli, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 20, 2026
Bilirubin as a Modulator of WNK1 Protein Signaling: Implications for Neuroinflammatory DiseasesSri Jayanti, Libor Vítek, Silvia Gazzin, et al.
Pageof 30